Page contentsPage contents Key facts Decision Key facts Active substance benzoyl peroxide (hydrous) Therapeutic area Skin and subcutaneous tissue disorders Decision number EMA/PE/0000233717 PIP number EMA/PE/0000233717 Pharmaceutical form(s) Cream Condition(s) / indication(s) Treatment of rosacea Route(s) of administration Topical use Contact for public enquiries Galenica AB Tel. +46 (0)40321095 E-mail: info@galenica.se Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 21/03/2025 Compliance check done No Decision EMA/PE/0000233717: EMA decision of 21 March 2025 on the granting of a product specific waiver for benzoyl peroxide (hydrous)Adopted Reference Number: EMADOC-1700519818-1975046 English (EN) (241.13 KB - PDF)First published: 17/06/2026 View Share this page